Drug and Therapeutics Bulletin 1995;33:86-88; doi:10.1136/dtb.1995.331186
Copyright © 1995 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Patient pack prescribing and the provision of patient information leaflets

In most of Western Europe prescribed medicines, accompanied by patient information leaflets, are dispensed by pharmacists in packs provided by the manufacturer. Up until now, pharmacists in the UK have usually bought medicines in bulk and then repacked and dispensed them in individually labelled bottles or cartons without leaflets. Over the next three years the patient pack dispensing system (original pack plus patient information) will be introduced in the UK. The new scheme has been devised to allow the UK to meet European legislation on patient information which requires that by December 1998 patients are provided with detailed written information about the drug(s) that is dispensed.^1–3 In this article we discuss how the scheme will be introduced and how it will affect patients, pharmacists and doctors.

This article has been cited by other articles:

				T Walley and P. Burrill Generic prescribing: time to regulate the market? BMJ, January 15, 2000; 320(7228): 131 - 132. [Full Text]